PepGen Inc. - Common Stock — Flux de trésorerie trimestriel (NASDAQ:PEPG) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 150.88 M127.39 M102.24 M190.06 M173.91 M156.29 M Total du passif 32.26 M35.59 M31.08 M26.92 M26.46 M22.32 M Total des capitaux propres 118.62 M91.81 M71.16 M163.14 M147.44 M133.98 M Total du passif et des capitaux propres 150.88 M127.39 M102.24 M190.06 M173.91 M156.29 M Dette totale —————— Dette nette ——————

Nouvelles

H.C. Wainwright réitère sa recommandation sur l’action PepGen

PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PepGen (PEPG) Upgraded to Buy: Here's What You Should Know

Tesla, Intel, IBM TO Report Earnings Next Week

Q1 Earnings Kick Off With Major Banks' Results: Bank Of America, Netflix In Focus

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.49%

PepGen Plunges On Mixed Phase 2 Data, But Higher Dose Could Offer Some Relief

McCormick et Nike grimpent en préouverture ; Phreesia chute

Pourquoi l'action de PepGen baisse-t-elle mardi ? | Benzinga France

PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data - Slideshow (NASDAQ:PEPG) 2026-03-31

PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data Transcript

L’action PepGen chute de 44% suite à des résultats d’essai décevants